COVID-19 surveillance (as of 1 March 2021)
176,757
coronavirus genomes sequenced by the Sanger Institute
315,585
coronavirus genomes sequenced by the COVID-19 Genomics UK (COG-UK) consortium
638,330
coronavirus genomes sequences available worldwide
Sanger Seminar: Comprehensive genomic surveillance of SARS-CoV-2 in the UK
Seminar: Exploring how the the Sanger Institute sequences SARS-CoV-2 genomes, and how this data is used by the COVID-19 Genomics UK (COG-UK) Consortium for surveillance and new variant identification; including the B.1.1.7 variant.
Q&A session with Dr Jeff Barrett, Director the Wellcome Sanger Institute COVID-19 Genomics Initiative.
Sanger's COVID-19 sequencing operation
17 million
samples received and handled since March 2020
300
Sanger staff have contributed so far
7
days a week operation
Human Cell Atlas COVID-19 research
Through our collaborations within the Human Cell Atlas initiative, a number of our research teams are exploring how the SARS-CoV-2 virus interacts with the cells in the body to gain access and cause symptoms.
To find out more about this work, please visit: https://www.humancellatlas.org/covid-19/
